SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-24-050789
Filing Date
2024-02-28
Accepted
2024-02-28 17:01:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d800901dsc14d9a.htm SC 14D9/A 19652
2 EX-99.(A)(5)(K) d800901dex99a5k.htm EX-99.(A)(5)(K) 63156
3 GRAPHIC g800901g21e94.jpg GRAPHIC 4432
  Complete submission text file 0001193125-24-050789.txt   91117
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filed by) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-87950 | Film No.: 24696560
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)